EASL Video Podcasts

EASL Video Podcasts

By European Association for the Study of the Liver (EASL)Education
Download on the App Store

EASL Video Podcasts episodes

  • EASL DeepDive: Key Updates in the EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma

    This EASL Deep Dive explores key updates from the EASL Clinical Practice Guidelines on hepatocellular carcinoma (HCC), with a practical focus on diagnosis and treatment selection. Experts will discuss evolving imaging and diagnostic criteria, patient selection for surgery and locoregional therapies, and how to adapt management according to response to systemic treatment. The session will also highlight the growing importance of multidisciplinary, individualised care across the HCC treatment pathway.

    1 hr 6 min
  • A joint EASL-ERN RARE-LIVER DeepDive – Wilson’s disease: a 2026 update

    The following objectives will be addressed in this EASL Deep Dive episode:

    • Have a profound knowledge of the pitfalls, limitations and difficulty of interpretation of the different tests of copper metabolism and liver copper assessments
    • Be able to establish a diagnostic approach to Wilson’s disease, integrating clinical, laboratory, genetic and imaging tools
    • Have a good understanding of the different treatment modalities, how to position them in the disease course, how to monitor treatment and what to expect as a result/outcome?

      • This EASL DeepDive webinar is supported by Orphalan and Univar Solutions. Orphalan and Univar Solutions have had no input into the content of this EASL DeepDive.

      1 hr 6 min
    • EASL DeepDive: Key Updates in the EASL Clinical Practice Guidelines on extrahepatic Cholangiocarcinoma (eCCA)

      In this EASL DeepDive webinar, the expert panel presents and explains the key studies behind the latest recommendations included in the EASL Clinical Practice Guidelines on the management of extrahepatic cholangiocarcinoma.

      Learning Objectives

      • To identify patients at risk for eCCA, and review the current tools and strategies for its surveillance, diagnosis, staging, and classification
      • To define the optimal candidates for resection and liver transplantation, and discuss challenges in the surgical management of eCCA
      • To discuss the role of systemic therapy in the management of eCCA across all disease stages (including neoadjuvant, adjuvant, and palliative settings)

        • Faculty

        • Luca Maroni - Moderator
        • Julie Heimbach - Speaker
        • Anna Saborowski - Speaker
        • Lars Aabakken - Speaker
          • 1 hr 8 min
        • EASL DeepDive: Key Changes in the New EASL HBV Guidelines

          In this EASL DeepDive, experts will discuss the latest advances in the EASL Clinical Practice Guidelines on the management of hepatitis B virus infection, published in the "Journal of Hepatology" in 2025.

          Learning objectives

          • Understand the updated EASL recommendations for initiating and discontinuing antiviral therapy in chronic hepatitis B, including key differences with other HBV guidelines. Participants will be able to identify treatment indications and make informed decisions about when and how to stop antiviral therapy.
          • Learn how to monitor patients with hepatitis B across different clinical scenarios, including those not on treatment, those receiving antiviral therapy, surveillance for hepatocellular carcinoma, risk of reactivation, and response to vaccination, in alignment with the new EASL guidelines.
          • Explore future directions in the management of chronic hepatitis B as outlined in the EASL guidelines, including advances in nomenclature and antiviral therapies under development.

            • Faculty

            • Markus Cornberg - Moderator
            • Maud Lemoine - Speaker
            • Sabela Lens - Speaker
            • Jerzy Jaroszewicz - Speaker
              • 1 hr 17 min
            • EASL DeepDive: EASL Clinical Practice Guidelines on the management of autoimmune hepatitis

              In this EASL DeepDive, experts will discuss the latest advances in the EASL Clinical Practice Guidelines on the management of autoimmune hepatitis, published in the "Journal of Hepatology" in 2025.

              Learning objectives

              • Select induction and maintenance treatment strategies aimed at achieving complete biochemical response
              • Recognise and manage disease flares, treatment intolerance, and suboptimal response in autoimmune hepatitis
              • Understand tailored approaches to autoimmune hepatitis management in specific patient groups

                • Faculty

                • Mária Papp - Moderator
                • Michael Heneghan - Speaker
                • George Dalekos - Speaker
                • Maria Carlota Londoño - Speaker
                  • 1 hr 20 min
                • EASL DeepDive: The Pursuit of a Cure: HCC Management Strategies

                  Hepatocellular carcinoma (HCC) is responsible for 75% of all primary liver cancers and is the third most prevalent cause of cancer death worldwide, with 900,000 new cases diagnosed each year. Many patients are diagnosed at an advanced stage, making curative treatment difficult.

                  In this DeepDive Webinar, you’ll be guided through the latest advances in hepatocellular carcinoma management, from the rising impact of immunotherapy combinations to evolving approaches in intermediate-stage disease. 

                  This EASL DeepDive webinar is supported by Bayer AG. Bayer AG has had no input into the content of this EASL DeepDive.

                  Learning Objectives

                  • What are strategies to optimise surveillance and early diagnosis of hepatocellular carcinoma
                  • What are the optimal candidates for surgery (including liver transplantation) and locoregional therapies (alone or combined with immunotherapy)
                  • Optimal selection of systemic front-line regimens and treatment sequencing after first-line immunotherapy

                    • Faculty

                    • Manon Allaire - Moderator
                    • Fabio Piscaglia - Speaker
                    • Antonio D'Alessio - Speaker
                    • Anna Saborowski - Speaker
                      • 1 hr 16 min
                    • EASL Studio Podcast: Collaborating across disciplines to find the best solution for people living with PBC

                      This EASL Studio episode brings key insights from the 2025 EASL–AASLD Consensus Conference on Primary Biliary Cholangitis (PBC).

                      Experts explore the use of surrogate endpoints, the challenges in current trial design and regulation, the value of real-world evidence, and how quality-of-life assessment can support future pathways.

                       

                      Moderator: David Jones

                      Speakers: Marco Carbone, Bettina Hansen, and Ana Lleo

                       

                      All EASL Studio Podcasts are available on EASL Campus.

                      Click here to see all EASL Video Podcasts on Apple Podcasts.

                      34 min
                    • EASL Studio Podcast: What Can Be Done to Safeguard Young Adults from SLD?

                      How can we protect young adults from steatotic liver disease (SLD)? This episode explores the burden of MASLD, MetALD, and ALD in Europe, the synergistic effects of alcohol and metabolic risk factors, and why the younger population is especially vulnerable. Experts also examine the disparities in risk factors and the role of clinics and policymakers in prevention.

                      Moderator: Shira Zelber Sagi

                      Speakers: Carina Ferreira-Borges (WHO representative) and Zobair Younossi

                      This EASL Studio is supported by Opella. EASL has received no input from Opella with regards to the content of this programme.

                      All EASL Studio Podcasts are available on EASL Campus.

                      Click here to see all EASL Video Podcasts on Apple Podcasts.

                      42 min
                    • EASL Studio Podcast: Decoding AASLD The Liver Meeting: Trends Shaping Hepatology

                      What were the key takeaways from this year’s AASLD The Liver Meeting? In this episode, experts unpack the most impactful studies, clinical insights, and emerging trends shaping the future of hepatology. From liver cancer breakthroughs to MASLD, ALD, and beyond.

                      Moderator: Debbie Shawcross

                      Speakers: Saul Karpen, Allison Kwong, Mazen Noureddin

                       

                      All EASL Studio Podcasts are available on EASL Campus.

                      Click here to see all EASL Video Podcasts on Apple Podcasts.

                      37 min
                    • EASL Studio Podcast: Rifaximin for Hepatic Encephalopathy: Balancing Benefits and Risks in the Era of Antimicrobial Resistance

                      For World Antimicrobial Awareness Week 2025 (“Act Now: Protect Our Present, Secure Our Future”), this EASL Studio explores the balance between rifaximin’s benefits in hepatic encephalopathy and the global challenge of antimicrobial resistance.

                      Moderator: Debbie Shawcross

                      Speakers: Rajiv Jalan, Vishal Patel, Jonel Trebicka

                      All EASL Studio Podcasts are available on EASL Campus.

                      Click here to see all EASL Video Podcasts on Apple Podcasts.

                       

                      This EASL Studio is supported by Alfasigma and Norgine. EASL has received no input from Alfasigma or Norgine with regards to the content of this programme.

                      38 min

                    About EASL Video Podcasts

                    From the publisher's feed

                    The EASL Podcasts in video channel showcases educational episodes derived from the EASL Studio, the EASL DeepDive webinars and the EASL Policy Dialogues. Watch, listen to and stay abreast of the…